These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 12388670)

  • 81. Endogenous 5-HT, released by MDMA through serotonin transporter- and secretory vesicle-dependent mechanisms, reduces hippocampal excitatory synaptic transmission by preferential activation of 5-HT1B receptors located on CA1 pyramidal neurons.
    Mlinar B; Corradetti R
    Eur J Neurosci; 2003 Sep; 18(6):1559-71. PubMed ID: 14511335
    [TBL] [Abstract][Full Text] [Related]  

  • 82. MDMA and fenfluramine alter the response of the circadian clock to a serotonin agonist in vitro.
    Biello SM; Dafters RI
    Brain Res; 2001 Nov; 920(1-2):202-9. PubMed ID: 11716826
    [TBL] [Abstract][Full Text] [Related]  

  • 83. (+/-)-3,4-Methylenedioxymethamphetamine administration to rats does not decrease levels of the serotonin transporter protein or alter its distribution between endosomes and the plasma membrane.
    Wang X; Baumann MH; Xu H; Morales M; Rothman RB
    J Pharmacol Exp Ther; 2005 Sep; 314(3):1002-12. PubMed ID: 15937150
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Evidence for a role of energy dysregulation in the MDMA-induced depletion of brain 5-HT.
    Darvesh AS; Gudelsky GA
    Brain Res; 2005 Sep; 1056(2):168-75. PubMed ID: 16098955
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain: immunocytochemical evidence for neurotoxicity.
    O'Hearn E; Battaglia G; De Souza EB; Kuhar MJ; Molliver ME
    J Neurosci; 1988 Aug; 8(8):2788-803. PubMed ID: 2457659
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Neurotoxic effects of the alpha-ethyl homologue of MDMA following subacute administration.
    Johnson MP; Nichols DE
    Pharmacol Biochem Behav; 1989 May; 33(1):105-8. PubMed ID: 2476831
    [TBL] [Abstract][Full Text] [Related]  

  • 87. A study of the neurotoxic effect of MDMA ('ecstasy') on 5-HT neurones in the brains of mothers and neonates following administration of the drug during pregnancy.
    Colado MI; O'Shea E; Granados R; Misra A; Murray TK; Green AR
    Br J Pharmacol; 1997 Jun; 121(4):827-33. PubMed ID: 9208155
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Serotonin mediates rapid changes of striatal glucose and lactate metabolism after systemic 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") administration in awake rats.
    Gramsbergen JB; Cumming P
    Neurochem Int; 2007 Jul; 51(1):8-15. PubMed ID: 17475367
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Enhancement of 3,4-methylenedioxymethamphetamine neurotoxicity by the energy inhibitor malonate.
    Nixdorf WL; Burrows KB; Gudelsky GA; Yamamoto BK
    J Neurochem; 2001 Apr; 77(2):647-54. PubMed ID: 11299327
    [TBL] [Abstract][Full Text] [Related]  

  • 90. The substituted amphetamines 3,4-methylenedioxymethamphetamine, methamphetamine, p-chloroamphetamine and fenfluramine induce 5-hydroxytryptamine release via a common mechanism blocked by fluoxetine and cocaine.
    Berger UV; Gu XF; Azmitia EC
    Eur J Pharmacol; 1992 May; 215(2-3):153-60. PubMed ID: 1356787
    [TBL] [Abstract][Full Text] [Related]  

  • 91. 3,4-Methylenedioxymethamphetamine (MDMA) neurotoxicity in rats: a reappraisal of past and present findings.
    Baumann MH; Wang X; Rothman RB
    Psychopharmacology (Berl); 2007 Jan; 189(4):407-24. PubMed ID: 16541247
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Repeated exposure to MDMA provides neuroprotection against subsequent MDMA-induced serotonin depletion in brain.
    Bhide NS; Lipton JW; Cunningham JI; Yamamoto BK; Gudelsky GA
    Brain Res; 2009 Aug; 1286():32-41. PubMed ID: 19555677
    [TBL] [Abstract][Full Text] [Related]  

  • 93. 3,4-Methylenedioxymethamphetamine produces glycogenolysis and increases the extracellular concentration of glucose in the rat brain.
    Darvesh AS; Shankaran M; Gudelsky GA
    J Pharmacol Exp Ther; 2002 Apr; 301(1):138-44. PubMed ID: 11907167
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Effects of fenfluramine, m-CPP and triazolam on repeated-acquisition in squirrel monkeys before and after neurotoxic MDMA administration.
    Winsauer PJ; McCann UD; Yuan J; Delatte MS; Stevenson MW; Ricaurte GA; Moerschbaecher JM
    Psychopharmacology (Berl); 2002 Feb; 159(4):388-96. PubMed ID: 11823891
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Effects of (+)-fenfluramine on 3,4-methylenedioxymethamphetamine (MDMA) discrimination in rats.
    Baker LE; Makhay MM
    Pharmacol Biochem Behav; 1996 Feb; 53(2):455-61. PubMed ID: 8808158
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Temperature and 3,4-methylenedioxymethamphetamine alter human serotonin transporter-mediated dopamine uptake.
    Saldaña SN; Barker EL
    Neurosci Lett; 2004 Jan; 354(3):209-12. PubMed ID: 14700733
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Environment-, drug- and stress-induced alterations in body temperature affect the neurotoxicity of substituted amphetamines in the C57BL/6J mouse.
    Miller DB; O'Callaghan JP
    J Pharmacol Exp Ther; 1994 Aug; 270(2):752-60. PubMed ID: 8071868
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Evidence for the involvement of nitric oxide in 3,4-methylenedioxymethamphetamine-induced serotonin depletion in the rat brain.
    Darvesh AS; Yamamoto BK; Gudelsky GA
    J Pharmacol Exp Ther; 2005 Feb; 312(2):694-701. PubMed ID: 15456837
    [TBL] [Abstract][Full Text] [Related]  

  • 99. A neurotoxic dose of 3,4-methylenedioxymethamphetamine (MDMA; ecstasy) to rats results in a long-term defect in thermoregulation.
    Mechan AO; O'Shea E; Elliott JM; Colado MI; Green AR
    Psychopharmacology (Berl); 2001 Jun; 155(4):413-8. PubMed ID: 11441431
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Chlormethiazole, dizocilpine and haloperidol prevent the degeneration of serotonergic nerve terminals induced by administration of MDMA ('Ecstasy') to rats.
    Hewitt KE; Green AR
    Neuropharmacology; 1994 Dec; 33(12):1589-95. PubMed ID: 7539115
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.